Indication
Cardiac Event
2 clinical trials
4 products
Product
Lansoprazole/DomperidoneProduct
LansoprazoleClinical trial
Cardiac Safety Evaluation of Lansoprazole/Domperidone 30/30 mg Sustained Release Capsule FormulationStatus: Withdrawn, Estimated PCD: 2018-12-01
Clinical trial
Effect of Xenon on Brain Injury, Neurological Outcome and Survival in Patients After Aneurysmal Subarachnoid HemorrhageStatus: Not yet recruiting, Estimated PCD: 2026-12-31
Product
XenonProduct
air/oxygen